Immune checkpoints are immunological "brakes" that prevent the over-activation of the immune system on healthy cells. Scientists have identified a human (host) protein that weakens the immune response to HIV and other viruses.
"Our study provides critical insight on a paramount issue in HIV research: Why is the body unable to mount an efficient immune response to HIV to prevent transmission?" said one of the researchers Sumit Chanda, professor and director of Sanford Burnham Prebys Medical Discovery Institute (SBP) in the US.
First Case of Alzheimer’s Diagnosed in a HIV-Positive Patient
Chronic HIV infection and amyloid deposition with aging may represent a double-hit to the brain that results in progressive dementia.
Advertisement
‘Deficiency in NLRX1 - an intracellular protein - reduces the replication of the HIV virus, and slows down the power of immune system.’
Tweet it Now
The findings showed that a deficiency in NLRX1 -- an intracellular protein -- reduces the replication of the HIV virus. It also slows down the power of immune system and promotes immunity to infection.
"Importantly, we were able to show that deficiencies in NLRX1 reduce HIV replication, suggesting that the development of small molecules to modulate the innate immune response may inhibit viral transmission and promote immunity to infection," Chanda added, in the paper published in the journal Cell Host and Microbe.
![HIV Vaccine Candidate Shows Promise in Preclinical Study]( "HIV Vaccine Candidate Shows Promise in Preclinical Study")
Mymetics has produced the tested HIV vaccine construct for clinical trials in liquid form and is developing a new generation of needle-free vaccine construct.
Further, host immune checkpoints that control the immune response to cancer were also discovered. "This research expands our understanding of the role of host proteins in viral replication and the innate immune response to HIV infection, and can be extended to DNA viruses such as HSV and vaccinia," added another researcher Haitao Guo, postdoctoral research associate at University of North Carolina.
Immune checkpoints are immunological "brakes" that prevent the over-activation of the immune system on healthy cells. Tumour cells often take advantage of these checkpoints to escape detection of the immune system. The results have important implications for improving HIV antiviral therapies, creating effective viral vaccines, and advance a new approach to treat cancer, the team concluded.
Source: IANS
HIV Vaccine Candidate Shows Promise in Preclinical Study
Mymetics has produced the tested HIV vaccine construct for clinical trials in liquid form and is developing a new generation of needle-free vaccine construct.
Advertisement
Further, host immune checkpoints that control the immune response to cancer were also discovered. "This research expands our understanding of the role of host proteins in viral replication and the innate immune response to HIV infection, and can be extended to DNA viruses such as HSV and vaccinia," added another researcher Haitao Guo, postdoctoral research associate at University of North Carolina.
Immune checkpoints are immunological "brakes" that prevent the over-activation of the immune system on healthy cells. Tumour cells often take advantage of these checkpoints to escape detection of the immune system. The results have important implications for improving HIV antiviral therapies, creating effective viral vaccines, and advance a new approach to treat cancer, the team concluded.
Source: IANS
HIV Agencies in United States Yield Insights on Improving Services
Agencies that serve people with HIV are at the forefront of delivering medical care, shelter, psycho-social counseling and other services to their vulnerable clients.
Advertisement
 Mandatory Pre-marital HIV Tests in TurkmenistanThe law applies to blood donors as well as it aims to create conditions for healthy families and prevent the birth of HIV-infected children. | Advertisement
|
Advertisement
Recommended Reading
Latest AIDS/HIV News
In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.
How can you prevent HIV while breastfeeding? A monthly vaginal ring containing the antiretroviral drug dapivirine safely prevents HIV infection while breastfeeding.
Union Minister of State for Health Bharti Pravin Pawar had said that the government is providing free lifelong antiretroviral (ARV) medicines for people living with HIV.
Dr. Korosi said the goal to end AIDS by 2030 is badly off track, as inequalities, discrimination, and disregard for human rights are hampering our progress.